DDL 2017 drew 750 delegates, a record number, to the Edinburgh International Conference Centre. Topics that received sustained attention over the course of the 3-day meeting included the use of modeling techniques, development of inhaled antibiotics for diseases such as tuberculosis, the lessons of e-cigarettes, and the use of acoustics for inhaler monitoring and … [Read more...] about DDL 2017 in review
Features
Recent advances in inhalation science will be featured at DDL 2017
The 700-plus OINDP specialists expected to convene at the Edinburgh International Conference Centre December 6-8 for this year's Drug Delivery to the Lungs (DDL) meeting will notice a few small changes designed to further the meeting's mission of encouraging inhalation research and to accommodate the growing numbers of delegates and exhibitors, organizers say. One … [Read more...] about Recent advances in inhalation science will be featured at DDL 2017
21st ISAM Congress focused on emerging trends
The 21st Congress of the International Society for Aerosols in Medicine (ISAM), held in Santa Fe, New Mexico June 3-7, 2017 featured presentations and posters covering recent advances in a wide range of topics related to aerosol drug delivery, including novel methods of modeling, trends in device design, and new therapies, and several new devices were on display in … [Read more...] about 21st ISAM Congress focused on emerging trends
RDD Europe 2017 focused on new technology
RDD Europe 2017 which took place April 25-28, 2017 at the Palais des Congrès in Antibes, France, drew almost 500 attendees from 32 countries, the largest RDD Europe meeting to date, organizers said. Throughout the course of the program and exhibition, the focus was on new technology, especially in the form of connected devices, with a number of presenters also … [Read more...] about RDD Europe 2017 focused on new technology
RDD Europe returns to Antibes
For RDD Europe 2017, to be held April 25-28, 2017 at the Palais des Congrès in Antibes, France, organizers RDD Online and Aptar Pharma expect approximately 450 OINDP experts to attend the 3-day conference. Two years ago, the 10th anniversary edition of RDD Europe, which was also held in Antibes, attracted 440 delegates from 31 countries. RDD Online's Richard Dalby … [Read more...] about RDD Europe returns to Antibes
Paul Kippax of Malvern Instruments answers questions about MDRS
Using morphologically-directed Raman spectroscopy (MDRS) for generic nasal spray development. Q:Last year, the FDA published an article titled “The FDA Embraces Emerging Technology for Bioequivalence Evaluation of Locally Acting Nasal Sprays” in which the FDA’s Bing Li said that the agency was very happy to have accepted MDRS data in lieu of a clinical endpoint BE … [Read more...] about Paul Kippax of Malvern Instruments answers questions about MDRS
Extrafine particles and the potential for enhanced inhaled drug delivery: A Q&A with Chiesi’s Dave Lewis
Q: What benefits are offered by extrafine particles? A: There is growing evidence to suggest that finer aerosols may enable us to effectively direct particles into more efficacious areas of the lung and to achieve a more uniform localized response. Furthermore, data we presented at RDD 2016 demonstrate that finer particles could deliver performance that is more … [Read more...] about Extrafine particles and the potential for enhanced inhaled drug delivery: A Q&A with Chiesi’s Dave Lewis
ISAM’s plans for 2017 include 21st Congress in Santa Fe, NM
The International Society for Aerosols in Medicine (ISAM) has planned a number of activities for 2017 in line with its mission “to stimulate and further the interdisciplinary cooperation and exchange of information in all aspects of aerosol research in medicine including health effects of inhaled aerosols and pulmonary drug delivery,” including the society’s 21st … [Read more...] about ISAM’s plans for 2017 include 21st Congress in Santa Fe, NM
DDL 27 showcased new technologies and targets for inhaled drugs
While acknowledging the 60th anniversary of the metered dose inhaler, the 27th annual Drug Delivery to the Lungs meeting devoted much of its program to looking forward beyond conventional devices, formulations, and targets. More than 700 delegates to DDL 27, held December 7-9 at the Edinburgh International Conference Center, heard presentations focused on the use of … [Read more...] about DDL 27 showcased new technologies and targets for inhaled drugs
Mexichem discusses potential for using HFA 152a as pMDI propellant
Following the signing of an international phase-down agreement regarding fluorinated gases in October 2016, pMDI propellent supplier Mexichem stated that it "does not believe the recent Kigali Amendment to the Montreal Protocol, nor regulatory controls such as the European F-Gas Regulation or US SNAP, will affect the availability of HFA medical propellants in the … [Read more...] about Mexichem discusses potential for using HFA 152a as pMDI propellant